DocSym
β
Searchsearch
Search
(G61.9) Inflammatory polyneuropathy, unspecified
More details coming soon
593 520 in individuals diagnosis inflammatory polyneuropathy, unspecified confirmed
13 133 deaths with diagnosis inflammatory polyneuropathy, unspecified
2% mortality rate associated with the disease inflammatory polyneuropathy, unspecified
Diagnosis inflammatory polyneuropathy, unspecified is diagnosed Men are 27.97% more likely than Women
379 763
Men receive the diagnosis inflammatory polyneuropathy, unspecified
7 523 (2.0 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
213 757
Women receive the diagnosis inflammatory polyneuropathy, unspecified
5 610 (2.6 %)Died from this diagnosis.
Risk Group for the Disease inflammatory polyneuropathy, unspecified - Men aged 60-64 and Women aged 55-59
In Men diagnosis is most often set at age 0-94
Less common in men the disease occurs at Age 95+Less common in women the disease occurs at Age 0-1, 95+
In Women diagnosis is most often set at age 0-94
Disease Features inflammatory polyneuropathy, unspecified
Absence or low individual and public risk
Inflammatory polyneuropathy, unspecified - what does this mean
Inflammatory polyneuropathy is an autoimmune disorder in which the body's immune system mistakenly attacks the peripheral nerves. this results in inflammation of the peripheral nerves, which can cause pain, numbness, tingling, and weakness in the arms and legs.
What happens during the disease - inflammatory polyneuropathy, unspecified
Inflammatory polyneuropathy is a group of disorders that are caused by an immune-mediated attack on the peripheral nerves. this leads to inflammation of the myelin sheath, the protective covering of the nerves, which can cause nerve damage and a wide range of symptoms including muscle weakness, numbness, and tingling. this damage can be caused by either an autoimmune disorder, such as guillain-barré syndrome, or an infection, such as lyme disease, which can trigger an immune response.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete physical examination
- Neurological examination
- Blood tests (including ANA, ESR, CRP, and CBC)
- Nerve conduction studies
- Electromyography (EMG)
- Magnetic resonance imaging (MRI)
- Cerebrospinal fluid (CSF) analysis
- Genetic tests
Treatment and Medical Assistance
Main Goal: To reduce inflammation and improve nerve function
- Prescription medication to reduce inflammation
- Physical therapy to improve nerve function
- Occupational therapy to improve daily functioning
- Counseling to help with emotional support
- Alternative treatments such as acupuncture or massage
- Nutritional support to maintain healthy nerve function
- Exercise to improve mobility
31 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Inflammatory polyneuropathy, unspecified - Prevention
Inflammatory polyneuropathy, unspecified can be prevented by avoiding exposure to known triggers, such as toxins, drugs, and infections; maintaining a healthy lifestyle, including a balanced diet and regular exercise; avoiding smoking and excessive alcohol consumption; and getting regular check-ups and vaccinations.